For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected ...

Some jellyfish possess the extraordinary ability to revert their cells back to an earlier developmental stage, effectively ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

ER-100 is being tested to restore vision by resetting the biological age of eye cells through epigenetic reprogramming, ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the close of a ...